MARA's bottom line is dominated by mark-to-market swings on its Bitcoin holdings, which drove most of last quarter's $611.3 ...
With Alphabet GOOGL) and Amazon AMZN) reporting negative free cash flow amid massive AI infrastructure spending, free cash flow (FCF) is becoming one of the most important metrics for evaluating ...
Agreement covers conversion of one 767-300BCF aircraft and secures options for two more PLANO, Texas, Nov. 2, 2026 ...
For the fourth consecutive year, Walmart is teaming up with Operation Homefront ® to help customers support military and ...
Callan JMB, Inc. (NASDAQ: CJMB) has received a complete QuickStrip oral thin-film production line from Rapid Dose Therapeutics Corp., marking a step towards establishing domestic pharmaceutical ...
GRAND CAYMAN, CAYMAN ISLANDS / ACCESS Newswire / November 2, 2026 / Moolec Science SA in Voluntary Liquidation (Nasdaq:MLEC) (the "Company") today announced that it received a Staff Delisting ...
IRVINE, CA / ACCESS Newswire / November 2, 2026 / American Vanguard Corporation announced today that it will report financial results for the quarter ended September 30, 2026, on Monday, November 9, ...
The Recapitalization eliminates approximately $96 million of annual cash interest on the Senior Notes Substantial new capital and liquidity: $400 million of new money through a rights offering of new ...
Rivian Automotive (NASDAQ:RIVN) shares climbed 3.2% to $12.55 in pre-market trading after UBS upgraded the electric vehicle manufacturer from Neutral to Buy and established a $17 price target, citing ...
The live and archived webcast can also be accessed by visiting the Nuvectis Pharma website on the Events and Presentations section of the Investor Relations page. A replay of the webcast will be ...
Chairman and CEO Khurram Sheikh will host the live call on Wednesday, November 4, 2026 at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time; investors may register now and submit questions through the ...
Updated TUPELO results featured in a Presidential Plenary at CGA-IGC: Lisa Boardman, M.D., Professor of Medicine at Mayo Clinic, presented updated findings from the Phase 1b/2 TUP ...